Differentiating founder and chronic HIV envelope sequences

Significant progress has been made in characterizing broadly neutralizing antibodies against the HIV envelope glycoprotein Env, but an effective vaccine has proven elusive. Vaccine development would be facilitated if common features of early founder virus required for transmission could be identifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, John M., Maher, Stephen, Mota, Talia, Suzuki, Kazuo, Kelleher, Anthony D., Center, Rob J., Purcell, Damian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302377/
https://www.ncbi.nlm.nih.gov/pubmed/28187204
http://dx.doi.org/10.1371/journal.pone.0171572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302377/
https://www.ncbi.nlm.nih.gov/pubmed/28187204
http://dx.doi.org/10.1371/journal.pone.0171572

Ejemplares similares